PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Nov-2024 Global Electrophoresis Market Set for Remarkable Growth, Projected to Reach USD 3,523.50 Million by 2033 at a CAGR of 4.5% MARKITWIRED
06-Nov-2024 Global Urgent Care Market Poised for Remarkable Growth, Projected to Reach USD 40,828.4 Million by 2033 MARKITWIRED
06-Nov-2024 Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions Evotec SE
06-Nov-2024 Global Mast Cell Tumor Treatment Market Set to Reach USD 7,836.4 Million by 2034, Driven by Advancements in Diagnostic Technologies and Rising Awareness | FMI MARKITWIRED
06-Nov-2024 Global Critical Care Drugs Market to Reach USD 1,730 Million by 2034, Driven by Rising Demand for Advanced Therapies in Intensive Care Units | FMI MARKITWIRED
06-Nov-2024 Global Difficult-to-Express Protein Market Set for Strong Growth, Projected to Reach USD 10.3 Billion by 2034 MARKITWIRED
06-Nov-2024 Global Biotin Supplement Market Poised for Strong Growth, Projected to Reach USD 8,331.0 Million by 2033 Amid Rising Health Awareness and Demand for Nutritional Support | FMI MARKITWIRED
06-Nov-2024 Global Pediatric Clinical Trial Market Set for Remarkable Growth USD 31,661.0 million by 2034 as Demand for Child Health Solutions Surges | FMI MARKITWIRED
06-Nov-2024 Global Medical Bed Market to Surpass USD 5,469.0 million by 2033, Driven by Sustainability and Technological Innovation | FMI MARKITWIRED
05-Nov-2024 Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing AccessWire
05-Nov-2024 NHI Announces Retirement of W. Andrew Adams from the Board of Directors AccessWire
05-Nov-2024 NHI Announces Fourth Quarter 2024 Dividend AccessWire
05-Nov-2024 NHI Issues Investor Update AccessWire
05-Nov-2024 NHI Announces Third Quarter 2024 Results AccessWire
05-Nov-2024 Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting AccessWire
05-Nov-2024 CannapharmaRx to Complete Additional Shipment in November AccessWire
05-Nov-2024 Nouscom’s Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to ‘Intercept’ Cancer Nouscom
05-Nov-2024 Seaport Therapeutics Names Lauren White as Chief Financial Officer Seaport Therapeutics
05-Nov-2024 Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend AccessWire
05-Nov-2024 Leading digital insights consultancy, Creation Healthcare, and largest online global physician community, G-Med, announce historic partnership enabling comparative analysis of online conversations of millions of HCPs worldwide Creation Healthcare